Barclays Stock Earnings Reports

Barclays reported a resilient Q1 2026 driven by diversified income, efficiency gains and disciplined capital management. Group RoTE was 13.5% on revenues of £8.2bn (up 6% y/y) and a cost-to-income ratio improved to 56%. Key positives included NII growth (group NII expected >£13.5bn for 2026), strengthening investment bank activity (IB income >£4bn, IB RoTE ~15%) and strong returns from U.K. businesses and the U.S. Consumer Bank. Management reiterated its targets for 2026 and 2028, announced a £500m buyback (part of a plan to return at least £15bn by 2028), and highlighted £150m of gross efficiencies towards a £2bn three‑year target. Q1 included a one‑off £228m single‑name impairment in securitized products (fraud-related) and a £105m motor‑finance provision (booked in head office) tied to legacy business redress, which contributed to an elevated quarter impairment charge of £823m (loan loss rate ~74bps). Barclays increased its structural hedge notional to £18.3bn (locking ~95% of 2026 hedge income), rolled hedge assets at ~3.9%, and said the Q1 deposit/lending behavior gives greater confidence in NII guidance. Management are constraining lending to counterparties with weak controls (private credit / certain structured finance counterparties) and reducing exposure to highly leveraged non‑investment grade corporates. Balance sheet metrics remain robust (CET1 14.1%, LDR ~75%, NSFR 135%, LCR 165%). Operational highlights: U.K. lending up ~5% y/y, mortgage activity with higher application volumes, Barclays U.K. RoTE ~19.7%, U.K. Corporate Bank RoTE ~19.9%, Private Bank RoTE ~25.5%, U.S. Consumer Bank RoCE ~18.8% with portfolio changes (American Airlines exit completed April; Best Egg acquisition expected early May). Management emphasized vigilance on macro and geopolitical risks but reiterated confidence in delivering their medium‑term targets.